35th Annual New Treatments in Chronic Liver Disease

Join us March 20-22, 2020 in San Diego!

Join us March 20-22, 2020 in San Diego!

New Treatments in Chronic Liver Disease will provide an update on commonly encountered problems in the treatment of liver disease.

Conference Location

Conference Location

Hilton San Diego Resort

1775 E Mission Bay Drive

San Diego, California 92109

Make a Reservation at the Hilton

Conference Details

Course Overview

This CME conference will review new medications and therapies that are now available, or will soon be available, and discuss their comparative values. The results of trials using new drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, cholangiocarcinoma, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.

Educational Objectives

After participating in this live activity, participants should be able to:

  • Understand the details of the AASLD guidelines for treatment of HCV using DAA’s in IFN-free regimens.
  • Review our current knowledge of NAFLD and non-alcoholic steatohepatitis and explore the use of new agents and approaches to treatment of the    conditions.
  • Integrate the algorithm for a therapeutic approach to treatment of HBV using anti-virals.
  • Discuss therapies for HCV including NS5A, protease and polymerase inhibitors.
  • Update the skills and management required for transplant hepatology.
  • Apply current options of therapy for hepatocellular carcinoma to determine the best approach for your patients.
  • Discuss future treatment paradigms for HCV direct-acting antiviral drug.
  • Describe the diagnosis and treatment of PBC and PSC.
  • Integrate treatment options discussed for patients with ESLD due to alcohol who have complicating factors such as HCV, NASH or inherited genetic disorder.
  • Discuss the issues complicating drug treatment in decompensated cirrhosis, hepatic encephalopathy and hyponatremia.
  • Review the management of complications beta-blocker therapy in ESLD.

Accreditation and Disclosures


Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Please note: ABIM MOC points will be awarded to those who successfully complete the requirements outlined in the post-conference evaluation. Points earned will be reported to the ABIM approximately 60 days post conference. These points will not appear on your CME certificate from Scripps.


For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit(s)™ issued by organizations accredited by the ACCME. For the purpose of re-licensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credit(s)™. The majority of state boards accept AMA PRA Category 1 Credit(s)™ as meeting continuing education requirements for license renewal. Nurses should check with their state’s Board of Registered Nursing regarding use of CME credit.

Physician Assistants

NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Commercial Support

This course is supported, in part, by educational grants from industry, in accordance with ACCME Accreditation Standards for Commercial Support. Appropriate acknowledgement will be given to all supporters at the time of the educational activity.

Cultural and Linguistic Competency

This activity is in compliance with California Assembly Bill 1195, which requires that all CME activities comprising a patient care element include curriculum addressing the topic of cultural and linguistic competency. The intent of this bill is to ensure that health care professionals are able to meet the cultural and linguistic concerns of a diverse patient population through effective and appropriate professional development. The planners, speakers and authors of this CME activity have been encouraged to address issues relevant in their topic area. A variety of resources are available that address cultural and linguistic competency, some of which can be found in the Cultural & Linguistic Competency Resource Guide.

Hilton San Diego Resort
1775 E Mission Bay Drive
San Diego, CA 92109
Get directions
Event details
Date Time
Fri, Mar 20th, 2020 - Sun, Mar 22nd, 2020 12:30 pm - 11:45 am